New hope for lung cancer patients with scarred lungs

NCT ID NCT07420439

Summary

This study aims to find safer and more effective treatments for people with advanced lung cancer who also have a separate lung-scarring disease (ILD). It will test a standard chemotherapy combination for patients receiving their first treatment, and test an immunotherapy drug for patients needing a second treatment. The main goals are to see if the cancer is controlled and to carefully monitor the safety of these drugs in people with fragile lungs.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Angers - CHU

    Angers, France

    Contact Email: •••••@•••••

  • Annecy - CH

    Pringy, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Besançon - CHU

    Besançon, France

    Contact Email: •••••@•••••

  • Bobigny - APHP - Hôpital Avicenne

    Bobigny, France

    Contact Email: •••••@•••••

  • Bordeaux - CHU

    Pessac, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Boulogne - APHP Ambroise Paré

    Boulogne-Billancourt, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Boulogne-Sur-Mer - CH

    Boulogne-sur-Mer, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Brest - CHU

    Brest, France

    Contact

  • Caen - CHU Côte de Nacre

    Caen, 14000, France

    Contact

  • Clermont-Ferrand - CHU

    Clermont-Ferrand, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Colmar - CH

    Colmar, 68000, France

    Contact

  • Créteil - CHI

    Créteil, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Dijon - CHU Bocage

    Dijon, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Grenoble - CHU

    Grenoble, 38000, France

    Contact

  • Lille - CHU

    Lille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Lyon - HCL

    Lyon, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Marseille - AP-HM Hôpital Nord

    Marseille, France

    Contact Email: •••••@•••••

  • Marseille - Institut Paoli Calmette

    Marseille, France

    Contact Email: •••••@•••••

  • Metz - Hôpital Robert Schuman

    Metz, France

    Contact Email: •••••@•••••

  • Montpellier - CHU

    Montpellier, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Nantes - CHU Hôpital Laënnec

    Nantes, France

    Contact Email: •••••@•••••

  • Paris - APHP - Tenon

    Paris, 75020, France

    Contact Email: •••••@•••••

  • Paris - APHP Bichat

    Paris, France

    Contact Email: •••••@•••••

  • Paris - APHP Cochin

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paris - APHP Pitié-salpêtrière

    Paris, France

    Contact Email: •••••@•••••

  • Paris - Saint Joseph

    Paris, France

    Contact Email: •••••@•••••

  • Rennes - CHU

    Rennes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Strasbourg - NHC

    Strasbourg, 63000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Suresnes - Foch

    Suresnes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tours - CHU

    Tours, France

    Contact Email: •••••@•••••

  • Villefranche-Sur-Saône - Hôpital Nord-Ouest

    Villefranche-sur-Saône, France

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.